VENLID: The Application of a 10%-Lidocaine Spray Prior to the Insertion of a Peripheral Intra-venous Catheter in Female Adults

Summary

Volunteers are invited to undergo 4 insertions of a peripheral intra-venous 18-gauge catheter (PIVC); 2 insertions at the the start of the study on the plantar side of the hand/vessel at the dorsum manus, 2 insertions after 2-10 hours into the forearm/cubita with and without application of a 10-% lidocaine spray (5 hubs of xylocaine 10%-pump spray; AstraZeneca BV, Zoetermeer, The Netherlands) prior to the insertion of the PIVC.

Timeline

Start

2024-05-07

Primary completion

2024-05-22

Completion

2024-05-22

Outcome

Missed primary endpoint

registry Hand: Vessel at the Dorsum Manus - Placebo vs Hand: Vessel at the Dorsum Manus- 10% Lidocaine LA; p = 0.398 NCT06354816 ↗

registry Forearm/Cubita - Placebo vs Forearm/Cubita - Lidocaine 10% LA; p = 0.550 NCT06354816 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lidocaine	Other / unclassified	50 mg	Topical

Indications

No indication recorded.